Live SK08 powder for mild to moderate ulcerative colitis
Part of Digestive system clinical trials.
This study tests if a live bacterial powder (SK08) can help people with active mild to moderate ulcerative colitis. It aims to see if it improves symptoms and is safe to take.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have mild to moderate ulcerative colitis diagnosed for at least 3 months with active symptoms like rectal bleeding and inflammation seen on a colonoscopy.
- Your colitis extends beyond the rectum (more than 15 cm from the anus).
- You have tried standard treatment (5-ASA) and it didn't work well enough or caused side effects.
- You can avoid certain medicines like steroids, antibiotics, anti-diarrhea drugs, probiotics, and biologics for a period before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests an investigational drug called LIV001 in people with mild-to-moderate ulcerative colitis. It aims to see if the medicine can help calm inflammation in the colon and improve symptoms.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This trial tests an oral tablet called AC-101 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation in the colon and improve symptoms.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.